News
BSX
98.65
+0.88%
0.86
Here's Why You Should Add PacBio Stock to Your Portfolio
NASDAQ · 9h ago
Boston Scientific’s AXIOS™ Gastroenterostomy Trial Paused: What Investors Should Watch
TipRanks · 9h ago
Boston Scientific’s RAINBOW Study: What the Hot AXIOS™ Update Means for Investors
TipRanks · 9h ago
Is Boston Scientific (BSX) Pricing In Too Much Growth After Strong Multi‑Year Share Gains
Simply Wall St · 11h ago
Despite Reassurances On Growth, The Market Hasn't Warmed To Stryker
Seeking Alpha · 12h ago
If You Invested $1000 in Boston Scientific 10 Years Ago, This Is How Much You'd Have Now
NASDAQ · 12h ago
Becton Dickinson price target raised to $215 from $210 at Stifel
TipRanks · 13h ago
Boston Scientific (BSX) Beats Stock Market Upswing: What Investors Need to Know
NASDAQ · 1d ago
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection
NASDAQ · 1d ago
If You Invested $100 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today
Benzinga · 1d ago
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth
NASDAQ · 1d ago
Boston Scientific price target lowered to $112 from $113 at Evercore ISI
TipRanks · 2d ago
Bank of America Securities Reaffirms Their Buy Rating on Boston Scientific (BSX)
TipRanks · 2d ago
Weekly Report: what happened at BSX last week (1229-0102)?
Weekly Report · 2d ago
INBS Stock Surges 132.4% on New Manufacturing Partnership
NASDAQ · 5d ago
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results
PR Newswire · 5d ago
A Look Into Boston Scientific Inc's Price Over Earnings
Benzinga · 6d ago
All J.P. Morgan's top stock picks for 2026
Seeking Alpha · 12/31/2025 17:44
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
NASDAQ · 12/31/2025 15:52
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform
NASDAQ · 12/31/2025 15:49
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.